1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces Analysis
5.3 Demand & Supply: Gap Analysis
5.4 Pricing analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition landscape
5.7 Upcoming Trends
6. Global Metastases spinal tumor Market by Type
6.1 Extradural
6.2 Metastatic Spinal Tumors of the Bone
6.3 Others
7. Global Metastases spinal tumor Market by Diagnosis
7.1 Metastatic Spinal Tumors of the Bone
7.2 Imaging tests
7.1.1 X-Ray
7.1.2 Computed Tomography (CT scan)
7.1.3 Magnetic Resonance Imaging (MRI scan)
7.1.4 Angiography
7.1.5 F-18 fluorodeoxyglucose positron emission tomography
7.1.6 Others
7.3 Biopsy
7.3.1 Percutaneous Needle Biopsy
7.3.2 Open Incisional and Excisional Biopsy
7.3.3 Others
7.4 Others
8. Global Metastases spinal tumor Market by Treatment
8.1 Non operative treatment
8.1.1 Medications
8.1.1.1 Anti-inflammatory drugs
8.1.1.2 Narcotics (opioids), Corticosteroids
8.1.1.3 RANKL inhibitors and bisphosphonates
8.1.1.4 Others
8.1.2 Radiation Therapy
8.1.3 Ablation
8.1.3.1 Radiofrequency ablation
8.1.3.2 Cryoablation
8.1.3.3 Others
8.1.4 Chemotherapy
8.1.5 Others
8.2 Surgical treatment
8.2.1 Minimally Invasive Surgery
8.2.1.1 Vertebral Fracture Treatments
8.2.1.1.1 Vertebroplasty
8.2.1.1.2 Kyphoplasty (Vertebral Augmentation)
8.2.1.1.3 Others
8.2.1.2 Transarterial Chemoembolization
8.2.1.3 Others
8.2.2 Open Surgery
8.2.2.1 Spinal Stabilization Surgery
8.2.2.2 Spinal Decompression Surgery
8.2.2.3 Others
8.2.3 Others
8.3 Others
9. Global Metastases spinal tumor Market by End User
9.1 Hospital and clinics
9.2 Ambulatory surgery centers
9.3 Academic institutes
9.4 Research centers
9.5 Others
10. Global Metastases spinal tumor Market by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 The US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of Asia
10.5 Pacific
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Egypt
10.6.4 Rest of the Middle East & Africa
11. Competitive Landscape
12. Company Profile
13. Conclusion
13.1 Key findings
13.1.1 From CEO’s viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Metastases Spinal Tumor Market
14. Appendix
